You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

W_pro1

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Educational Activities Trial in Montreal (Intervention)

Recruiting
  • Educational Activities
  • Intervention
  • Montreal, Quebec, Canada
    Institut de Recherches Cliniques de Montréal
Sep 2, 2022

Electrocardiographic Modifications and Spontaneous Hypoglycemic

Active, not recruiting
  • Type 1 Diabetes Mellitus
  • FreeStyle Libre Pro
  • Holter monitor
  • Montreal, Quebec, Canada
    Institut de recherches cliniques de Montréal
Mar 7, 2022

HIV, Human Immunodeficiency Virus Trial in San Francisco (PRO 140 350mg weekly SQ injection.)

Active, not recruiting
  • HIV
  • Human Immunodeficiency Virus
  • PRO 140 350mg weekly SQ injection.
  • San Francisco, California
    CD01-Extension Investigational Site
Sep 28, 2021

Dementia Prevention, Mild Cognitive Impairment, Subjective Cognitive Impairment Trial in Canada (Brain Health PRO)

Recruiting
  • Dementia Prevention
  • +3 more
  • Brain Health PRO
  • Vancouver, British Columbia, Canada
  • +5 more
May 26, 2022

Pre-Hospital Zone 1 Partial Resuscitative Endovascular Balloon

Completed
  • Emergencies
  • +2 more
  • Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA)
  • London, United Kingdom
  • +3 more
May 6, 2022

Infections, Meningococcal Trial in Worldwide (Meningococcal vaccine GSK134612, Prevenar 13™)

Completed
Has Results
  • Infections, Meningococcal
  • Meningococcal vaccine GSK134612
  • Prevenar 13™
  • Garran, Australian Capital Territory, Australia
  • +50 more
Sep 7, 2021

Adults With Severe Eosinophilic Asthma on Benralizumab.

Active, not recruiting
  • Severe Eosinophilic Asthma
  • Survey Administration
  • Calgary, Alberta, Canada
  • +19 more
Dec 1, 2022

Adv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian Cancer Trial in Worldwide (Administration of

Recruiting
  • Adv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian Cancer
  • Administration of ceralasertib in combination with carboplatin
  • +3 more
  • Duarte, California
  • +26 more
Aug 17, 2022

(PRO) Measures for Individuals With Neurofibromatosis 1 and

Recruiting
  • Neurofibromatosis 1
  • Plexiform Neurofibromas
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Venous Leg Ulcer Trial in Worldwide (Venous Leg Ulcer Standard of Care with Granulox)

    Active, not recruiting
    • Venous Leg Ulcer
    • Venous Leg Ulcer Standard of Care with Granulox
    • Split, Croatia
    • +26 more
    Jan 16, 2023

    Pneumococcal Disease Trial in Worldwide (20-valent pneumococcal conjugate vaccine, 13-valent pneumococcal conjugate vaccine)

    Active, not recruiting
    • Pneumococcal Disease
    • 20-valent pneumococcal conjugate vaccine
    • 13-valent pneumococcal conjugate vaccine
    • Nedlands, Western Australia, Australia
    • +63 more
    Nov 3, 2022

    HIV Trial in Puerto Rico, United States (PRO 140, Placebo, Optimized Background Regimen)

    Completed
    • HIV
    • PRO 140
    • +2 more
    • Fountain Valley, California
    • +36 more
    Sep 28, 2021

    Endstage Renal Disease Trial in Worldwide (Spironolactone 25Mg Tablet, Placebo Oral Tablet)

    Recruiting
    • Endstage Renal Disease
    • Spironolactone 25Mg Tablet
    • Placebo Oral Tablet
    • Garran, Australian Capital Territory, Australia
    • +85 more
    Sep 19, 2022

    Renal Cell Carcinoma, Nasopharyngeal Carcinoma, Non Hodgkin Lymphoma Trial in United States (PRO1160)

    Not yet recruiting
    • Renal Cell Carcinoma
    • +2 more
    • Detroit, Michigan
    • +4 more
    Jan 31, 2023

    Chronic Renal Failure Trial in Marseille (BLOOD SAMPLES)

    Recruiting
    • Chronic Renal Failure
    • BLOOD SAMPLES
    • Marseille, France
      Assistance Publique Hopitaux de Marseille
    Mar 9, 2023

    Hip Fractures Trial in Calgary (Rivaroxaban 10mg, acetylsalicylic acid (ASA) 81mg Oral Tablet)

    Not yet recruiting
    • Hip Fractures
    • Rivaroxaban 10mg
    • acetylsalicylic acid (ASA) 81mg Oral Tablet
    • Calgary, Alberta, Canada
      Foothills Medical Centre
    Mar 7, 2023

    B-type Natriuretic Peptide With N-terminal Pro B-type

    Recruiting
    • Perioperative Care
    • NT ProBNP (Roche)
    • Kingston, Ontario, Canada
      Kingston Health Sciences Centre
    Jun 29, 2022

    Atopic Dermatitis Trial in New York, Philadelphia (1.1% w/w AMTX-100 CF, 0.33% w/w AMTX-100 CF, 0.11% w/w AMTX-100 CF)

    Active, not recruiting
    • Atopic Dermatitis
    • 1.1% w/w AMTX-100 CF
    • +3 more
    • New York, New York
    • +1 more
    Sep 27, 2022

    Dysphagia Trial in Canada, United States (RE-ACTIVE, PRO-ACTIVE EAT, PRO-ACTIVE EAT + EXERCISE)

    Recruiting
    • Dysphagia
    • RE-ACTIVE
    • +2 more
    • Miami, Florida
    • +12 more
    Nov 24, 2022

    Pro-opiomelanocortin (POMC) Deficiency Obesity Trial in Worldwide (Setmelanotide, Placebo)

    Completed
    • Pro-opiomelanocortin (POMC) Deficiency Obesity
    • Scottsdale, Arizona
    • +6 more
    Jan 26, 2021

    Type 1 Diabetes Trial in Petach Tikva (DreaMed Advisor Pro, Medical guided recommendation)

    Recruiting
    • Type 1 Diabetes Mellitus
    • DreaMed Advisor Pro
    • Medical guided recommendation
    • Petach Tikva, Israel
      Schnider Children's medical center
    Feb 21, 2022

    Peri-implant Mucositis Trial in Pavia (Ozoral Pro and Ozoral gel administration, Curasept chlorhexidine gel 1%)

    Active, not recruiting
    • Peri-implant Mucositis
    • Ozoral Pro and Ozoral gel administration
    • Curasept chlorhexidine gel 1%
    • Pavia, Lombardy, Italy
      Unit of Dental Hygiene - Section of Dentistry - Department of Cl
    May 11, 2022

    Sarcoma, Melanoma Trial in Washington (Pro-GRID)

    Recruiting
    • Sarcoma
    • Melanoma
    • Pro-GRID
    • Washington, District of Columbia
      Sibley Memorial Hospital
    Oct 11, 2022

    Diabetes, Type 1 Trial in Nice (enhanced care model provided by Timkl, a home support provider)

    Recruiting
    • Diabetes Mellitus, Type 1
    • enhanced care model provided by Timkl, a home support provider
    • Nice, Paca, France
      CHU Nice - Hôpital l'Archet 2
    Sep 18, 2023

    HIV-1-infection Trial in San Francisco (PRO 140 350, PRO 140 525, PRO 140 700)

    Active, not recruiting
    • HIV-1-infection
    • PRO 140 350
    • +2 more
    • San Francisco, California
      Quest Clinical Research
    Mar 4, 2022